In vitro modulation of CD95 expression on a human glioblastoma cell line by various chemotherapeutic drugs

E. Ciusani, P. Perego, A. Salmaggi, N. Carenini, M. Eoli, A. Silvani, A. Boiardi, F. Zunino

Research output: Contribution to journalArticle

Abstract

The CD95-mediated pathway may be relevant in regulating drug sensitivity of tumor cells because this system, consisting of a membrane-bound isoform and its natural ligand (CD95L), might be modulated in response to drug treatment. In this study, using a CD95+ human glioblastoma cell line, we investigated the in vitro effects of various chemotherapeutic drugs on CD95 expression. Alterations in the susceptibility of this cell line to Fas-dependent apoptosis following drug exposure were also evaluated. Our results show that in vitro treatment of GBM cell with mitoxantrone, topotecan and CPT-83 induced an up-regulation of CD95 expression, whereas other drugs such as cisplatin and taxol did not. In the case of topotecan and CPT-83, the drug-induced up-regulation of CD95 was concomitant to an increased susceptibility of GBM cells to Fas-dependent apoptosis. The observed up-regulation of CD95 expression and Fas-dependent apoptosis might have important therapeutic implications because cells could be sensitive to specific DNA-damaging agents through activation of the CD95 pathway. The profile of expression of CD95 might be a useful additional tool in the choice of the optimal chemotherapeutic regimen in glioblastoma.

Original languageEnglish
JournalNeurological Sciences
Volume21
Issue number4 SUPPL.
Publication statusPublished - 2000

Fingerprint

Glioblastoma
Cell Line
Pharmaceutical Preparations
Topotecan
Up-Regulation
Apoptosis
Mitoxantrone
Fas Ligand Protein
Paclitaxel
Cisplatin
In Vitro Techniques
Protein Isoforms
Ligands
Membranes
DNA
Neoplasms

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

In vitro modulation of CD95 expression on a human glioblastoma cell line by various chemotherapeutic drugs. / Ciusani, E.; Perego, P.; Salmaggi, A.; Carenini, N.; Eoli, M.; Silvani, A.; Boiardi, A.; Zunino, F.

In: Neurological Sciences, Vol. 21, No. 4 SUPPL., 2000.

Research output: Contribution to journalArticle

@article{624ce7d2a9f14a36ac843fcc01041000,
title = "In vitro modulation of CD95 expression on a human glioblastoma cell line by various chemotherapeutic drugs",
abstract = "The CD95-mediated pathway may be relevant in regulating drug sensitivity of tumor cells because this system, consisting of a membrane-bound isoform and its natural ligand (CD95L), might be modulated in response to drug treatment. In this study, using a CD95+ human glioblastoma cell line, we investigated the in vitro effects of various chemotherapeutic drugs on CD95 expression. Alterations in the susceptibility of this cell line to Fas-dependent apoptosis following drug exposure were also evaluated. Our results show that in vitro treatment of GBM cell with mitoxantrone, topotecan and CPT-83 induced an up-regulation of CD95 expression, whereas other drugs such as cisplatin and taxol did not. In the case of topotecan and CPT-83, the drug-induced up-regulation of CD95 was concomitant to an increased susceptibility of GBM cells to Fas-dependent apoptosis. The observed up-regulation of CD95 expression and Fas-dependent apoptosis might have important therapeutic implications because cells could be sensitive to specific DNA-damaging agents through activation of the CD95 pathway. The profile of expression of CD95 might be a useful additional tool in the choice of the optimal chemotherapeutic regimen in glioblastoma.",
author = "E. Ciusani and P. Perego and A. Salmaggi and N. Carenini and M. Eoli and A. Silvani and A. Boiardi and F. Zunino",
year = "2000",
language = "English",
volume = "21",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "4 SUPPL.",

}

TY - JOUR

T1 - In vitro modulation of CD95 expression on a human glioblastoma cell line by various chemotherapeutic drugs

AU - Ciusani, E.

AU - Perego, P.

AU - Salmaggi, A.

AU - Carenini, N.

AU - Eoli, M.

AU - Silvani, A.

AU - Boiardi, A.

AU - Zunino, F.

PY - 2000

Y1 - 2000

N2 - The CD95-mediated pathway may be relevant in regulating drug sensitivity of tumor cells because this system, consisting of a membrane-bound isoform and its natural ligand (CD95L), might be modulated in response to drug treatment. In this study, using a CD95+ human glioblastoma cell line, we investigated the in vitro effects of various chemotherapeutic drugs on CD95 expression. Alterations in the susceptibility of this cell line to Fas-dependent apoptosis following drug exposure were also evaluated. Our results show that in vitro treatment of GBM cell with mitoxantrone, topotecan and CPT-83 induced an up-regulation of CD95 expression, whereas other drugs such as cisplatin and taxol did not. In the case of topotecan and CPT-83, the drug-induced up-regulation of CD95 was concomitant to an increased susceptibility of GBM cells to Fas-dependent apoptosis. The observed up-regulation of CD95 expression and Fas-dependent apoptosis might have important therapeutic implications because cells could be sensitive to specific DNA-damaging agents through activation of the CD95 pathway. The profile of expression of CD95 might be a useful additional tool in the choice of the optimal chemotherapeutic regimen in glioblastoma.

AB - The CD95-mediated pathway may be relevant in regulating drug sensitivity of tumor cells because this system, consisting of a membrane-bound isoform and its natural ligand (CD95L), might be modulated in response to drug treatment. In this study, using a CD95+ human glioblastoma cell line, we investigated the in vitro effects of various chemotherapeutic drugs on CD95 expression. Alterations in the susceptibility of this cell line to Fas-dependent apoptosis following drug exposure were also evaluated. Our results show that in vitro treatment of GBM cell with mitoxantrone, topotecan and CPT-83 induced an up-regulation of CD95 expression, whereas other drugs such as cisplatin and taxol did not. In the case of topotecan and CPT-83, the drug-induced up-regulation of CD95 was concomitant to an increased susceptibility of GBM cells to Fas-dependent apoptosis. The observed up-regulation of CD95 expression and Fas-dependent apoptosis might have important therapeutic implications because cells could be sensitive to specific DNA-damaging agents through activation of the CD95 pathway. The profile of expression of CD95 might be a useful additional tool in the choice of the optimal chemotherapeutic regimen in glioblastoma.

UR - http://www.scopus.com/inward/record.url?scp=33845345632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845345632&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33845345632

VL - 21

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 4 SUPPL.

ER -